case_images: PMC10998503_01
case_images: Clinical photographs at baseline. Extensive symmetrical red patches and papules with crusts and scales were observed on the patient's (a) face, (c) trunk, and (d and e) extremities. (b) The occipital scalp showed a coin-sized patch of hair loss.
case_images: JAA-17-305-g0001.jpg
case_images: PMC10998503_01_JAA-17-305-g0001.jpg
case_images: f0001
case_images: Physical examination showed extensive symmetrical red patches and papules with scales on his face, trunk, and extremities, notably accompanied by significant yellow crusts and exudates on his face [Investigator's Global Assessment (IGA) score of 5, Eczema Area Severity Index (EASI) score of 34] (Figure 1a, c-e). The occipital scalp showed a coin-sized patch of hair loss (Figure 1b).
case_images: Clinical photographs after 12 weeks of abrocitinib treatment. (a, c-e) The skin manifestations improved significantly, and (b) hair regrowth occurred in the affected area of the scalp.
case_images: JAA-17-305-g0002.jpg
case_images: PMC10998503_01_JAA-17-305-g0002.jpg
case_images: f0002
case_images: AD and treated with oral abrocitinib (200 mg/day). After 12 weeks of treatment, his skin manifestations improved significantly, and hair regrowth occurred in the affected area of the scalp [P-NRS score of 2/10, IGA score of 1, EASI score of 2.2] (Figure 2a-e).